The finding of a pathogenic variant in FANCM during this specific analysis is promising as it affirms our candidate gene rationale and to our knowledge, marks the first known case of a FANCM deleterious variant in an ovarian cancer patient. This evidence concerns the gene FANCM and ovarian carcinoma.